Top 15 Medical Device Angel Investors in Asia in November 2024

Last updated: Nov 2024 A list of 15 angel investors that invest in Medical device startups based in Asia. We rank investors based on the number of investments they made in Medical device companies from Asia. We update this investor list every month.

Top 15 Medical Device Angel Investors in Asia in November 2024

Investor	Medical Device Asia investments
Matt Cutts	1
Leonard Lynch	1
Vir Kashyap	1
Tony Tan Choon Keat	1
Benjamin Boyer	1
Eric Urhane	1
Paul Buchheit	1
Cherif Habib	1
Johannes Hille	1
Hao Yan	1
Avi Reichental	1
Yoshitsune Ido	1
Other Lenders	1
Jack Wang	1
Frederik Vandermarlie	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his

Investment focus

SaaS, Health Care, Software
Seed, Angel, Series A
United States, Canada, Mexico

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
X-ZELL — Early, pain-free cancer cell detection
Meter Feeder — Easily pay for parking through MeterFeeder

Leonard Lynch

Investment focus

Information Services, Education, Health Care
Seed
Sri Lanka, United States

Portfolio highlights

oDoc — Channel doctors now through online video consultations at your convenience through the oDoc Mobile App. Download now to consult top doctors of Sri Lanka.
Mainstay — Reach students and employees through SMS text messaging and webchat, and drive outcomes with AI messages and responses proven to spark positive behavior changes.

Vir Kashyap is the Director, International Strategy & Operations at Indeed.com.

Investment focus

Health Care, Mobile Apps, Construction
Seed, Pre-Seed
India, Singapore, Sri Lanka

Portfolio highlights

oDoc — Channel doctors now through online video consultations at your convenience through the oDoc Mobile App. Download now to consult top doctors of Sri Lanka.
Kolo — Home Construction App
VAMA — VAMA is a one-stop virtual platform that provides easy access to e-pujas, e-darshans, and astrology services, to devotees from across India and the world.

Tony Tan Choon Keat

Investment focus

Health Care, Finance, Biotechnology
Series B, Funding Round
Singapore

Portfolio highlights

Endofotonics Pte Ltd — “To reduce mortality and disease burden with objective real time molecular diagnosis during endoscopy, that is accessible to all.”
Biobot Surgical Pte Ltd — Biobot Surgical is a global technology provider in minimally-invasive robotic healthcare solutions.

Ben Boyer is a Managing Director of Tenaya Capital, and he has been a member of the Tenaya investment team since 2000.Previously, Ben was a member of Lehman Brothers' Technology Investment Banking group, where he was responsible for corporate finance and strategic advisory assignments.Ben holds an M.B.A. from Stanford Graduate Schoolof Business and a B.S. in human and organizational development from Vanderbilt University.

Investment focus

Software, E-Commerce, Internet
Series C, Seed, Series B
United States, China, Singapore

Portfolio highlights

Kangaroo — No hidden upfront costs or astronomical monthly monitoring fees. Our plans are contract-free, flexible and affordable. We even help you earn cash back on your insurance policy! Our sensors are batteries-included, peel-and-stick, app-controlled easy. Choose a free plan or professionally monitored plan for only $99/yr.
People.ai — Uncover the Fastest Path to Revenue
Triparound — Get access to the ultimate travel planning platform for maximized ancillary revenue and operational efficiency!

Eric Urhane

Investment focus

Software, Health Care, Biotechnology
Seed, Angel
United States, Mexico, Singapore

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
X-ZELL — Early, pain-free cancer cell detection
Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.

Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.